Cargando…
FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling
FAM172A, as a newly discovered gene, is little known in cancer development, especially in pancreatic cancer (PC). We investigated the potential role and molecular mechanism of FAM172A in epithelial to mesenchymal transition (EMT) in both human clinical samples and PC cells. FAM172A was downregulated...
Autores principales: | Chen, Ying, Liu, Peihui, Shen, Di, Liu, Han, Xu, Lepeng, Wang, Jian, Shen, Daguang, Sun, He, Wu, Hongkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044457/ https://www.ncbi.nlm.nih.gov/pubmed/31988090 http://dx.doi.org/10.1242/bio.048462 |
Ejemplares similares
-
Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020) -
Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
por: Sheng, Weiwei, et al.
Publicado: (2017) -
Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020) -
[Retracted] FAM172A induces S phase arrest of HepG2 cells via Notch 3
por: Feng, Zhiqiang, et al.
Publicado: (2023) -
FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter
por: QIAN, KAI, et al.
Publicado: (2016)